APA (7th ed.) Citation

Jiang, C., Shu, P., & Zhou, K. Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer: Perspectives from US and Chinese payers. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Jiang, Can, Pei Shu, and Kexun Zhou. Cost-effectiveness Analysis of Pembrolizumab Plus Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer: Perspectives from US and Chinese Payers. BMJ Publishing Group.

MLA (9th ed.) Citation

Jiang, Can, et al. Cost-effectiveness Analysis of Pembrolizumab Plus Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer: Perspectives from US and Chinese Payers. BMJ Publishing Group.